Recruiting Bladder Cancer Studies in Norwich
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
The objective of this study is to evaluate the efficacy and safety of sacituzumab govitecan-hziy monotherapy and with novel combinations in participants with metastatic urothelial cancer (mUC)....
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
This is a Phase Ib/IIb, randomized, two-cohort, open-label, multicenter study of intravesical N-803 plus BCG versus BCG alone, in BCG naïve patients with high-grade NMIBC....
About Bladder Cancer Clinical Trials in Norwich
Bladder cancer occurs in the tissues of the bladder and is one of the most common cancers. It has a high recurrence rate, requiring ongoing monitoring. Treatments include surgery, intravesical therapy, chemotherapy, and immunotherapy.
There are currently 2 bladder cancer clinical trials recruiting participants in Norwich, CONNECTICUT. These studies are seeking a combined 1,423 participants. Research is being sponsored by Gilead Sciences, ImmunityBio, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Bladder Cancer Clinical Trials in Norwich — FAQ
Are there bladder cancer clinical trials in Norwich?
Yes, there are 2 bladder cancer clinical trials currently recruiting in Norwich, CONNECTICUT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Norwich?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Norwich research site will contact you about next steps.
Are clinical trials in Norwich free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Norwich studies also compensate for your time and travel.
What bladder cancer treatments are being tested?
The 2 active trials in Norwich are testing new therapies including novel drugs, biologics, and treatment approaches for bladder cancer.
Data updated March 2, 2026 from ClinicalTrials.gov